retatrutide clinical trial results 2024 2025 press release Eli Lilly touts strong of new experimental weight loss drug retatrutide clinical trial results 2024

Eli Lilly have a new, once-monthly GLP1/GIP agonist (Brenipatide) and they're running some fascinating trials with it Smoking cessation, bipolar disorder, schizophrenia, opioid use disorder, depression, alcohol use disorder, and asthma Eli Lilly have a new, once-monthly GLP1/GIP agonist (Brenipatide) and they're running some fascinating trials with it Smoking cessation, bipolar disorder, schizophrenia, opioid use disorder, depression, alcohol use disorder, and asthma That it's dosed monthly probably makes it better suited to psychiatry/addiction settings, where adherence matters a lot I made the table with some inspiration from Lilly's investor deck: investor.lilly.com/static-files/4 interesting stuff

Nat Rev Gastroenterol Hepatol 8(7):385394

Diabetes 51(10):30253032

The peptides potential in sexual wellness has made it a subject of interest, though its effectiveness varies

Vitamin B12: Several studies have found that B12 can help improve sperm count and motility, as well as reduce sperm DNA damage